We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

139 hedge funds and large institutions have $1.03B invested in Arcus Biosciences in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

421% more call options, than puts

Call options by funds: $3.44M | Put options by funds: $661K

392% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 12

176% more capital invested

Capital invested by funds: $375M → $1.03B (+$660M)

100% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 24

51% more funds holding

Funds holding: 92 → 139 (+47)

14.61% more ownership

Funds ownership: 58.73% → 73.34% (+15%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
139
Holders Change
+47
Holders Change %
+51.09%
% of All Funds
2.85%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
59
Increased
48
Reduced
24
Closed
12
Calls
$3.44M
Puts
$661K
Net Calls
+$2.78M
Net Calls Change
+$2.79M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$70.9M
2
BI
BVF Inc
California
+$49.8M
3
EC
EcoR1 Capital
California
+$41M
4
FCM
Farallon Capital Management
California
+$27M
5
State Street
State Street
Massachusetts
+$25.5M

Top Sellers

1
PS
Peter Svennilson
-$47.9M
2
BC
Boxer Capital
California
-$27M
3
Verition Fund Management
Verition Fund Management
Connecticut
-$6.35M
4
ACM
Aisling Capital Management
New York
-$4.63M
5
HA
HHLR Advisors
Cayman Islands
-$3.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
76
ExodusPoint Capital Management
New York
$1.03M +$1.13M +41,698 New
Verition Fund Management
77
Verition Fund Management
Connecticut
$969K -$6.35M -235,403 -86%
Bank of America
78
Bank of America
North Carolina
$914K +$437K +16,194 +78%
EGI
79
EAM Global Investors
California
$913K +$996K +36,915 New
MCM
80
Moore Capital Management
New York
$866K +$945K +35,000 New
Qube Research & Technologies (QRT)
81
Qube Research & Technologies (QRT)
United Kingdom
$767K +$837K +30,997 New
UBS AM
82
UBS AM
Illinois
$762K +$832K +30,815 New
TI
83
Trexquant Investment
Connecticut
$726K +$82K +3,040 +12%
New York State Common Retirement Fund
84
New York State Common Retirement Fund
New York
$725K – – –
QI
85
QS Investors
New York
$701K +$764K +28,300 New
CCPM
86
Cooper Creek Partners Management
New York
$701K +$765K +28,342 New
Citigroup
87
Citigroup
New York
$654K +$454K +16,812 +175%
BAM
88
Blueshift Asset Management
New Jersey
$654K +$713K +26,423 New
Jane Street
89
Jane Street
New York
$575K +$628K +23,255 New
LI
90
Leap Investments
Illinois
$532K +$580K +21,500 New
TRCT
91
Tower Research Capital (TRC)
New York
$510K +$556K +20,619 New
AIG
92
American International Group
New York
$498K +$24.8K +919 +5%
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$468K -$47.4K -1,755 -8%
Bank Julius Baer & Co
94
Bank Julius Baer & Co
Switzerland
$467K -$526K -19,499 -50%
DTL
95
Dynamic Technology Lab
Singapore
$404K +$441K +16,340 New
MML Investors Services
96
MML Investors Services
Massachusetts
$400K -$536K -19,862 -55%
Rafferty Asset Management
97
Rafferty Asset Management
New York
$392K +$427K +15,826 New
MIM
98
MetLife Investment Management
New Jersey
$387K – – –
MGIM
99
M&G Investment Management
United Kingdom
$387K +$417K +15,470 New
SFI
100
Susquehanna Fundamental Investments
Pennsylvania
$371K +$405K +15,000 New
2 3
4
5 6

RCUS Hedge Fund Activity: Q2 2020 in Review

139 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q2 2020, worth a combined $1.03B — up 176% from $375M a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new RCUS positions and 12 closed out — a net gain of 47 holders — while 48 added to existing stakes and 24 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $70.9M. The largest seller was Peter Svennilson, cutting an estimated $47.9M.

  • 139 institutional investors held Arcus Biosciences (RCUS) as of Q2 2020, up from 92 in Q1 2020.
  • Funds reported $1.03B of Arcus Biosciences stock for Q2 2020, up 176% quarter-over-quarter.
  • 59 funds opened new Arcus Biosciences positions in Q2 2020 and 12 closed out, a net change of +47 holders.
  • The largest Arcus Biosciences buyer in Q2 2020 was Fidelity Investments, an estimated $70.9M added.
  • The largest Arcus Biosciences seller in Q2 2020 was Peter Svennilson, an estimated $47.9M sold.

Based on aggregated 13F filings for Q2 2020.